ARTICLE | Company News
Abbott selects more Celera targets
February 7, 2006 1:57 AM UTC
ABT selected for development two more cell surface antigens identified by CRA under the companies' 2004 cancer deal. ABT selected two initial targets last April. Under the deal, CRA has the option to ...